|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide,thalidomide,and prednisone for patients with relapsed or refractory multiple myeloma:A hoosier oncology group trial,HEM01-21显示文摘 | Suvannasankha A Fausel C Juliar BE | 2007 | Oncologist2007，12，1： | 1 |
| 2 | Serumn resistin (FIZZ3)protein is increased in obese humans显示文摘 | Degawa YM Bovenkerk JE Juliar BE | 2003 | J Clin Endocrinol Metab2003，88，11： | 1 |
| 3 | The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy 显示文摘 | Cheng L Koch MO Juliar BE | 2005 | J Clin Oncol2005，23，13： | 1 |
| 4 | Final report of toxicity and efficacy of a phase Ⅱ study of oral cydophosphamide,thalidomide,and prednisone for patients with relapsed or refractory multiple myeloma:A Hoosier Oncology Group Trial,HEM0121显示文摘 | Suvannasankha A Fausel C Juliar BE | 2007 | Oncologist2007，12，1： | 1 |
| 5 | Final report of toxicity and efficacy of a phase Ⅱ study of oral cyclophosphamide,thalidomide,and prednisone for patients with relapsed or refractory multiple myeloma:A hoosier oncology group trial,HEM01-21显示文摘 | Suvannasankba A Fausel C Juliar BE | 2007 | The Oncologist2007，12，1： | 1 |
| 6 | Final report of toxicity and efficacy of a phase Ⅱ study of oral cyclophosphamide,thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A HoosierOncology Group Trial, HEM01-21 显示文摘 | Suvannasankha A Fausel C Juliar B E | 2007 | Oncologist2007，12，1： | 1 |
| 7 | Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium:a phase Ⅱ Hoosier Oncology Group study显示文摘 | Li J Juliar B Yiannoutsos C | 2005 | J Clin Oncol2005，23，6： | 1 |
| 8 | Final report of toxicity and efficacy of a phase Ⅱ study of oral cyclophosphamide,thalidomide,and prednisone for patients with relapsed or refractnry multiple myeloma:a Hoosier oncology Group Trial,HEMO1-21 显示文摘 | Suvannasankha A Fausel C Juliar BE | 2007 | Oncologist2007，12，1： | 1 |
| 9 | Serum resistin (FIZZ3) protein is increased in obese humans显示文摘 | Degawa-Yamauchi M Bovenkerk JE Juliar BE | 2003 | J Clin Endocrinol Metab2003，88，11： | 1 |
| 10 | Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide,thalidomide,and prednisone for patients with relapsed or refractory multiple myeloma:a hoosier oncology group trial,HEM01-21显示文摘 | Suvannasankha A Fausel C Juliar BE | 2007 | Oncologist2007，12，1： | 1 |
| 11 | Serum resistin (FIZZ3) protein is increased in obese humans显示文摘 | DEGAWA-YAMAUCHI M BOVENKERK J E JULIAR B E | 2003 | J Clin Endocrinol Metab2003，88，11： | 1 |
| 12 | Serum resistin (FIZZ3) protein is increased in obese human显示文摘 | Degawa YM Bovenkerk JE Juliar BE | 2003 | J Clin Endocrinol Metab2003，88，： | 1 |
| 13 | Seruin resistin (FIZZ3 protein is increased in obese humans 显示文摘 | Degawa-Yamavchi M Bovenkerk JE Juliar JE | 2003 | J Clin Endocrinol Metab2003，88，： | 1 |
| 14 | Serum resistin(FIZZ3)protein is increased in obese humans显示文摘 | Degawa YM Bovenkerk JE Juliar BE | 2003 | J Clin Endocrinol Metab2003，88，11： | 1 |
| 15 | Provider Recommendations for Colorectal Cancer Screening in Elderly Veterans显示文摘 | Charles J. Kahi Michelle Ryn Beth Juliar Jennifer Schaffter Stuart Thomas F. Imperiale | 2009 | Journal of General Internal Medicine2009，，12： | 1 |
| 16 | Serum resistin (FIZZ3) protein is increased in obese humans显示文摘 | Degawa-Yamauchi M Bovenkerk J E Juliar B E | 2003 | J Clin Endocrinol Metab2003，88，11： | 1 |
| 17 | Serum resistin (FIZZ3) protein is increased in obese humans 显示文摘 | Degawa-Yamauchi M Bovenkerk J E Juliar B E | 2003 | Clin Endocrinol Metab2003，88，： | 1 |
| 18 | Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: a hoosier oncology group trial, HEM01-21 显示文摘 | Suvannasankha A Fausel C Juliar BE | 2007 | Oncologist2007，12，1： | 1 |
| 19 | Unscented filtering and nonlinear estimation显示文摘 | JULIAR S UHLMANN J K | 2004 | Proceeding of the IEEE2004，92，3： | 1 |
| 20 | Effect of screening colonoscopy on colorectal cancer incidence and mortality显示文摘 | Kahi CJ Imperiale TF Juliar BE | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员